Works matching IS 00223573 AND DT 2025 AND VI 77 AND IP 2
Results: 11
Roflumilast mitigates cisplatin-induced nephrotoxicity by regulating TNF-α/TNFR1/TNFR2/Fas/Caspase mediated apoptosis and inflammatory signals.
- Published in:
- Journal of Pharmacy & Pharmacology, 2025, v. 77, n. 2, p. 308, doi. 10.1093/jpp/rgae142
- By:
- Publication type:
- Article
The regulatory effects of mitragynine on P-glycoprotein transporter.
- Published in:
- Journal of Pharmacy & Pharmacology, 2025, v. 77, n. 2, p. 321, doi. 10.1093/jpp/rgae131
- By:
- Publication type:
- Article
Development of a pharmacokinetic/pharmacodynamic evaluation model for osteomyelitis and usefulness of tedizolid as an alternative to vancomycin against MRSA osteomyelitis.
- Published in:
- Journal of Pharmacy & Pharmacology, 2025, v. 77, n. 2, p. 291, doi. 10.1093/jpp/rgae124
- By:
- Publication type:
- Article
Systems pharmacology-based drug discovery from Amaryllidaceae alkaloids and investigation of mechanisms of action in treatment of Alzheimer's disease.
- Published in:
- Journal of Pharmacy & Pharmacology, 2025, v. 77, n. 2, p. 222, doi. 10.1093/jpp/rgae113
- By:
- Publication type:
- Article
Mechanism of traditional drug treatment of cancer-related ascites: through the regulation of IL-6/JAK-STAT3 pathway.
- Published in:
- Journal of Pharmacy & Pharmacology, 2025, v. 77, n. 2, p. 264, doi. 10.1093/jpp/rgae111
- By:
- Publication type:
- Article
Unravelling the role of dipeptidyl peptidases-8/9 (DPP-8/9) in inflammatory osteoporosis: a comprehensive study investigating chrysin as a potential anti-osteoporotic agent.
- Published in:
- Journal of Pharmacy & Pharmacology, 2025, v. 77, n. 2, p. 249, doi. 10.1093/jpp/rgae109
- By:
- Publication type:
- Article
A prediction method for the individual serum concentration and therapeutic effect for optimizing adalimumab therapy in inflammatory bowel disease.
- Published in:
- Journal of Pharmacy & Pharmacology, 2025, v. 77, n. 2, p. 299, doi. 10.1093/jpp/rgae092
- By:
- Publication type:
- Article
Pyrazolone-nicotinic acid derivative (4Z)-4-(2-hydroxybenzylidine)-5-methyl-2-(pyridine-3-ylcarbonyl)-2, 4-dihydro-3H-pyrazole-3-one (IIc) as multitarget inhibitor of neurodegeneration and behavioural impairment in Dementia.
- Published in:
- Journal of Pharmacy & Pharmacology, 2025, v. 77, n. 2, p. 275, doi. 10.1093/jpp/rgae075
- By:
- Publication type:
- Article
The natural polyphenol fisetin in atherosclerosis prevention: a mechanistic review.
- Published in:
- Journal of Pharmacy & Pharmacology, 2025, v. 77, n. 2, p. 206, doi. 10.1093/jpp/rgae053
- By:
- Publication type:
- Article
Phytochemical profile and hepatoprotective potentiality of Phyllanthus genus: a review.
- Published in:
- Journal of Pharmacy & Pharmacology, 2025, v. 77, n. 2, p. 189, doi. 10.1093/jpp/rgae040
- By:
- Publication type:
- Article
Trilobatin regulates glucose metabolism by ameliorating oxidative stress and insulin resistance in vivo and in vitro.
- Published in:
- Journal of Pharmacy & Pharmacology, 2025, v. 77, n. 2, p. 236, doi. 10.1093/jpp/rgae035
- By:
- Publication type:
- Article